Published in Curr Med Res Opin on August 01, 2007
A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol (2007) 1.71
Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev (2009) 0.92
Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS One (2011) 0.85
Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. Cochrane Database Syst Rev (2009) 0.85
Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study. BMC Pulm Med (2013) 0.81
Educational and decision-support tools for asthma-management guideline implementation. Asia Pac Allergy (2012) 0.80
Advances in device and formulation technologies for pulmonary drug delivery. AAPS PharmSciTech (2014) 0.77
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). NPJ Prim Care Respir Med (2016) 0.75
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. Transplantation (2000) 1.84
Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J (2010) 1.78
COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract (2014) 1.63
[Guidelines for diagnosis and treatment of asthma patients]. Pneumologie (2006) 1.59
[Rare diseases in pulmonary medicine and its challenges]. Pneumologie (2012) 1.39
[beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League]. Dtsch Med Wochenschr (2007) 1.39
[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study]. Pneumologie (1999) 1.38
[Chronic obstructive pulmonary disease (COPD)]. Dtsch Med Wochenschr (2012) 1.38
Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med (1997) 1.29
Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med (1996) 1.22
Electrophoretic characterization of wheat grain allergens from different cultivars involved in bakers' asthma. Electrophoresis (1993) 1.16
Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome. Intensive Care Med (2000) 1.16
Suppression of pulmonary innate host defence in smokers. Thorax (2008) 1.12
Lymphangioleiomyomatosis: recurrence after single lung transplantation. Hum Pathol (1997) 1.09
Molecular basis of the liver and lung disease associated with the alpha 1-antitrypsin deficiency allele Mmalton. J Biol Chem (1989) 1.05
Automatic CPAP titration with different self-setting devices in patients with obstructive sleep apnoea. Eur Respir J (2004) 1.04
TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens (2005) 1.03
Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol (1985) (1993) 1.02
Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling. Eur Respir J (2005) 1.00
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci U S A (1990) 0.99
Humidifier lung and humidifier fever. Lung (1988) 0.99
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J (2004) 0.98
Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase. J Clin Invest (1991) 0.97
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. Clin Nutr (2006) 0.96
Oxidant-protease interaction in the lung. Prospects for antioxidant therapy. Chest (1996) 0.96
Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur Respir J (1996) 0.95
Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res (1996) 0.93
Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine. Eur Respir J (2002) 0.93
Occupational asthma in hairdressers: results of inhalation tests with bleaching powder. Int Arch Occup Environ Health (1997) 0.92
A prospective polysomnographic study on the evolution of complex sleep apnoea. Eur Respir J (2011) 0.92
Peripheral airspace dimensions in patients with COPD. Chest (1995) 0.92
Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele. Mol Cell Biol (1990) 0.92
[Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET]. Dtsch Med Wochenschr (2010) 0.91
Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur Respir J (1995) 0.91
Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparison. Environ Health Perspect (1997) 0.91
[Health effects of particulate matter exposure: current scientific knowledge]. Pneumologie (2009) 0.91
Airflow limitation, lung volumes and systemic inflammation in a general population. Eur Respir J (2011) 0.91
Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin Diagn Lab Immunol (2001) 0.89
The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation. Transpl Infect Dis (2001) 0.89
Functional significance of cardiac reinnervation in heart transplant recipients. J Heart Lung Transplant (1999) 0.89
Transforming growth factor-beta1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a bronchial epithelial cell line. Munich Lung Transplant Group. Eur Respir J (2000) 0.89
Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection? Eur Respir J (2002) 0.87
Analysis of sleep fragmentation and sleep structure in patients with sleep apnea and normal volunteers. Conf Proc IEEE Eng Med Biol Soc (2005) 0.86
Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity. Am J Respir Crit Care Med (1999) 0.86
Neutrophil proteinases and rhDNase therapy in cystic fibrosis. Eur Respir J (1996) 0.85
Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation. The Munich Lung Transplant Group. Transplantation (2000) 0.83
Tacrolimus (FK506) as primary immunosuppressant after lung transplantation. Thorac Cardiovasc Surg (1999) 0.82
The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing. Curr Med Res Opin (2004) 0.81
["Malignant" ARDS]. Internist (Berl) (2009) 0.81
The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis (2012) 0.81
Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols. Transplant Proc (2001) 0.80
Biochemical and cellular composition of alveolar epithelial lining fluid in anesthetized healthy lambs. Eur J Med Res (1997) 0.80
Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA. Curr Med Res Opin (2010) 0.80
A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany. Int J Clin Pract (2008) 0.80
[The German registry of individuals with alpha-1-antitrypsin deficiency--a source for research on patient care]. Pneumologie (2008) 0.79
[Why is obstructive sleep apnea (OSA) a cardiovascular risk factor?]. Z Kardiol (2003) 0.79
Peripheral arterial tonometry for the diagnosis of obstructive sleep apnea. Biomed Tech (Berl) (2002) 0.78
Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up. Respiration (1997) 0.78
A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. J Breath Res (2016) 0.78
Inhibition of factor XIIIa-mediated incorporation of fibronectin into fibrin by pulmonary surfactant. Am J Physiol (1999) 0.78
[Acute dyspnoea]. Internist (Berl) (2005) 0.78
Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers? Drugs Aging (1998) 0.78
Optimization of the immunosuppressive protocol after lung transplantation. Transplantation (1999) 0.78
Lung function and cardiopulmonary exercise performance after heart transplantation: influence of cardiac allograft vasculopathy. Chest (1999) 0.78
Cardiopulmonary exercise testing before and after lung and heart-lung transplantation. Am J Respir Crit Care Med (1999) 0.78
Inhaled nitric oxide (NO) for the treatment of early allograft failure after lung transplantation. Munich Lung Transplant Group. Intensive Care Med (1998) 0.78
[Differential diagnoses of dyspnoea]. Internist (Berl) (2007) 0.78
[Guidelines for diagnosing extrinsic allergic alveolitis (hypersensitivity pneumonitis) (German Extrinsic Allergic Alveolitis Study Group)]. Pneumologie (2007) 0.78
All-trans retinoic acid results in irregular repair of septa and fails to inhibit proinflammatory macrophages. Eur Respir J (2011) 0.77
[Therapy of lung diseases with anti-oxidants]. Pneumologie (1994) 0.77
Pulmonary glutathione levels in acute episodes of Farmer's lung. Am J Respir Crit Care Med (2000) 0.77
[Chronic obstructive pulmonary disease : new pharmacotherapeutic options]. Internist (Berl) (2012) 0.77
Detection of bronchial breathing caused by pneumonia. Biomed Tech (Berl) (2002) 0.77
[Chronic obstructive pulmonary disease (COPD) as a systemic disease]. Dtsch Med Wochenschr (2009) 0.77
Sarcoidosis recurrence following lung transplantation. Transplantation (1996) 0.77
Ambulatory recording of sleep apnea using peripheral arterial tonometry. Conf Proc IEEE Eng Med Biol Soc (2004) 0.77
[Alpha-1-antitrypsin deficiency: diagnosis and therapy of the lung disease]. Pneumologie (2009) 0.77
[Reflux-associated respiratory tract diseases: asthma, chronic cough, sleep apnea. Epidemiology, diagnosis and therapy]. Internist (Berl) (2003) 0.76
[The new GOLD document]. Pneumologie (2012) 0.76
[Treatment of bronchial asthma using a new adjustable combination treatment plan: Asthma Control Plan (ATACO)]. Pneumologie (2001) 0.76
Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Respir Med (2006) 0.76
[Interferon-gamma is necessary for the expression of hypersensitivity alveolitis]. Pneumologie (1997) 0.76
Immunophenotyping of lymphocyte subsets in bronchoalveolar lavage fluid. Comparison of flow cytometric and immunocytochemical techniques. J Immunol Methods (1992) 0.76
Much ado about nothing? Eur Respir J (2006) 0.75
[Quo vadis ECMO?]. Pneumologie (2001) 0.75
IPF or NSIP? That is the question. Eur Respir J (2003) 0.75
[Chronic obstructive pulmonary disease: from pathogenesis to treatment]. Dtsch Med Wochenschr (2008) 0.75
[Inhalable corticosteroids in long-term COPD treatment. Opinions of an expert panel]. Pneumologie (2000) 0.75
[Solid combination of budesonide and formoterol in the treatment of bronchial asthma]. Pneumologie (2001) 0.75
Cardiopulmonary exercise testing following hay exposure challenge in farmer's lung. Eur Respir J (1997) 0.75
Tacrolimus-based immunosuppressive protocols in lung transplantation. Transplant Proc (1999) 0.75
[Clinical significance of gastrooesophageal reflux in asthma]. Pneumologie (2006) 0.75
[Virtual and three-dimensional bronchoscopy with spiral and electron beam computed tomography]. Radiologe (1998) 0.75
Relations between cardiopulmonary exercise testing and quantitative high-resolution computed tomography associated in patients with alpha-1-antitrypsin deficiency. Eur J Med Res (1998) 0.75
[Acute exacerbation of COPD]. Pneumologie (2006) 0.75
[Nocturnal long-term recording of breath sounds in patients with bronchial asthma -- a reasonable diagnostic option?]. Pneumologie (2005) 0.75
[The 10-minute consultation: hemoptysis]. MMW Fortschr Med (2007) 0.75